pindolol has been researched along with Kidney Failure, Chronic in 17 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mepindolol was rapidly absorbed in all the patients." | 1.27 | Pharmacokinetics of mepindolol in patients with chronic renal failure. ( Fischer, HC; Kampf, D; Krause, W, 1984) |
| " The initial rate of absorption was inversely correlated with creatinine clearance." | 1.26 | Pharmacokinetics of intravenous and oral pindolol in hypertensive patients with chronic renal failure. ( Chau, NP; Levenson, JA; Safar, ME; Simon, AC; Weiss, YA, 1978) |
| " The initial rate of absorption was inversely correlated with the creatinine clearance." | 1.26 | Pindolol availability in hypertensive patients with normal and impaired renal function. ( Chau, NP; Georges, DR; Lavene, DE; Milliez, PL; Safar, ME; Weiss, YA, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (88.24) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodde, OE | 1 |
| Daul, A | 1 |
| Zumkley, H | 1 |
| Wagner, H | 1 |
| Hoffmanns, H | 1 |
| Seetzen-Kanaan, G | 1 |
| Vetter, H | 2 |
| Zideck, W | 1 |
| Raidt, H | 1 |
| Kellinghaus, H | 1 |
| Balant, L | 1 |
| Krause, W | 1 |
| Kampf, D | 1 |
| Fischer, HC | 1 |
| Ohnhaus, EE | 2 |
| Heidemann, H | 1 |
| Meier, J | 1 |
| Maurer, G | 1 |
| Lübbecke, F | 1 |
| Safar, M | 1 |
| Weiss, Y | 1 |
| Chau, NP | 3 |
| Kheder, A | 1 |
| Levenson, J | 1 |
| Milliez, P | 1 |
| Fillastre, JP | 1 |
| Godin, M | 1 |
| Safar, ME | 2 |
| Levenson, JA | 1 |
| Simon, AC | 1 |
| Weiss, YA | 2 |
| De Ferrari, G | 1 |
| Gaiter, A | 1 |
| Ginevri, F | 1 |
| Tizianello, A | 1 |
| Galeazzi, RL | 1 |
| Gugger, M | 1 |
| Weidmann, P | 1 |
| Lavene, DE | 1 |
| Georges, DR | 1 |
| Milliez, PL | 1 |
| MacDonald, NJ | 1 |
| Grant, AC | 1 |
| Rodger, RS | 1 |
| Meredith, PA | 1 |
| Elliott, HL | 1 |
| Souchet, T | 1 |
| Brée, F | 1 |
| Baatard, R | 1 |
| Fontenaille, C | 1 |
| D'Athis, P | 1 |
| Tillement, JP | 1 |
| Kiechel, JR | 1 |
| Lhoste, F | 1 |
| Groth, H | 1 |
| Achermann, R | 1 |
| Kuhlmann, U | 1 |
| Siegenthaler, W | 1 |
| Vetter, W | 1 |
| Snell, A | 1 |
| Wallace, M | 1 |
2 reviews available for pindolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Hepatic clearance of drugs in kidney failure].
Topics: Adrenergic beta-Antagonists; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Liver; Metabolic | 1983 |
[Dosage of digitalis glycosides and beta blockers in renal insufficiency].
Topics: Adrenergic beta-Antagonists; Creatinine; Digitalis Glycosides; Digoxin; Humans; Kidney Failure, Chro | 1976 |
1 trial available for pindolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Diuretics and antihypertensive agents in chronic kidney insufficiency: comparison of the effects of metolazone and furosemide].
Topics: Adult; Aged; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hydralazine; Hyperten | 1985 |
14 other studies available for pindolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Alpha- and beta-adrenoceptor changes in patients on maintenance hemodialysis.
Topics: Adenylyl Cyclases; Adult; Aged; Cyclic AMP; Female; Humans; Iodocyanopindolol; Isoproterenol; Kidney | 1984 |
[Immediate effect of beta receptor blockaders on electrolyte metabolism].
Topics: Adrenergic beta-Antagonists; Electrolytes; Humans; Hypertension; Kidney Failure, Chronic; Metoprolol | 1982 |
Pharmacokinetics of mepindolol in patients with chronic renal failure.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Female; Humans; Kidney Failure, Chronic; Kinetics | 1984 |
Metabolism of pindolol in patients with renal failure.
Topics: Aged; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Middle Aged; Models, Biological; Pindolo | 1982 |
Myocardial alterations in chronic experimental renal failure.
Topics: Animals; Atrial Function, Left; Atropine; Carbachol; Cardiomyopathies; Dobutamine; Kidney Failure, C | 1994 |
[Pharmacokinetics of beta-blockers in arterial hypertension. Practical value].
Topics: Adrenergic beta-Antagonists; Blood Pressure; Depression, Chemical; Humans; Hypertension; Kidney Fail | 1978 |
[Treatment by beta-blockers of arterial hypertension in patients with chronic renal insufficiency on hemodialysis].
Topics: Acebutolol; Adrenergic beta-Antagonists; Humans; Hypertension, Renal; Kidney Failure, Chronic; Pindo | 1978 |
Pharmacokinetics of intravenous and oral pindolol in hypertensive patients with chronic renal failure.
Topics: Administration, Oral; Adult; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Liver; Metabolic | 1978 |
[Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency].
Topics: Adult; Aged; Blood Pressure; Female; Humans; Hypertension; Hypertension, Renal; Kidney Failure, Chro | 1979 |
beta blockade with pindolol: differential cardiac and renal effects despite similar plasma kinetics in normal and uremic man.
Topics: Adult; Aldosterone; Heart Rate; Humans; Kidney Failure, Chronic; Pindolol; Renal Dialysis; Renin | 1979 |
Pindolol availability in hypertensive patients with normal and impaired renal function.
Topics: Administration, Oral; Adult; Biological Availability; Creatinine; Humans; Hypertension; Injections, | 1977 |
The effect of renal impairment on the pharmacokinetics and metabolism of bopindolol.
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Hypertension; Kidney; Kidney Failure, Chronic; M | 1991 |
Impaired regulation of beta 2-adrenergic receptor density in mononuclear cells during chronic renal failure.
Topics: Adult; Age Factors; Aged; Catecholamines; Female; Humans; In Vitro Techniques; Iodocyanopindolol; Ki | 1986 |
Letter: Beta-blockade in the presence of renal disease and hypertension.
Topics: Acute Kidney Injury; Adrenergic beta-Antagonists; Analgesics; Female; Humans; Hypertension; Kidney F | 1974 |